Science & Technology

Public Health Experts Advocate Typhoid Vaccine Integration into Immunization Schedule

31 August 2026UPSCSSC

In Brief

Health experts advocate integrating Typhoid Conjugate Vaccines into India's Universal Immunization Programme to curb drug-resistant Salmonella.

Leading public health specialists and epidemiologists issued a consensus recommendation urging the Ministry of Health and Family Welfare to integrate Typhoid Conjugate Vaccines (TCV) into India's flagship Universal Immunization Programme (UIP). The call comes amid growing clinical concern over the widespread empirical misuse of antibiotics leading to Antimicrobial Resistance (AMR) in *Salmonella enterica* serovar Typhi strains across the country.

Typhoid fever is a life-threatening bacterial disease transmitted through contaminated food and water. While older polysaccharide vaccines offered short-lived protection and were ineffective in infants, Typhoid Conjugate Vaccines (TCVs) confer longer-lasting immunity, require fewer doses, and can be administered safely to children under two years of age alongside routine childhood immunizations.

Key technical parameters for examinees: Typhoid is caused by *Salmonella Typhi*. India accounts for a disproportionately high burden of global typhoid cases. The World Health Organization (WHO) recommended TCV for infants above 6 months in typhoid-endemic countries. Integrating TCV into UIP aims to reduce pediatric hospitalization and combat Extensive Drug-Resistant (XDR) typhoid strains resistant to fluoroquinolones and third-generation cephalosporins.

UPSC Study NotesHIGHGS2 — Health & Public Health Policy; GS3 — Science & Technology (Biotechnology/Disease Management)

GS2 — Health & Public Health Policy; GS3 — Science & Technology (Biotechnology/Disease Management)

📌 Exam Angle

Prelims may ask: "Which vaccine is recommended by WHO for typhoid-endemic countries in infants above 6 months?" or "Typhoid is caused by which pathogen?" Mains essays could demand: "How can vaccine integration into UIP address both communicable disease burden and antimicrobial resistance in India?" or case studies on balancing preventive healthcare costs against disease burden reduction.

⚠️ Key Concerns

UPSC loves probing implementation challenges—cost of TCV integration into UIP, equity in vaccine access across rural-urban India, and vaccine hesitancy. The AMR angle is critical: why empirical antibiotic misuse persists despite policy frameworks, and whether vaccination alone addresses the root cause of XDR typhoid emergence.

💡 Why It Matters

India bears disproportionate global typhoid burden with emerging XDR strains rendering fluoroquinolones and third-generation cephalosporins ineffective—making prevention via vaccination a strategic public health imperative. This exemplifies India's dual challenge: reducing infectious disease mortality while combating AMR through evidence-based preventive strategies aligned with WHO recommendations.

🔑 Must Remember

• Typhoid Conjugate Vaccines (TCV) are superior to older polysaccharide vaccines—longer immunity, effective in infants <2 years, fewer doses required • Salmonella enterica serovar Typhi causes typhoid; XDR strains resist fluoroquinolones and third-generation cephalosporins • WHO recommends TCV for infants ≥6 months in endemic countries; integration into UIP is preventive AMR strategy

📝 Key Terms

Typhoid Conjugate VaccineSalmonella TyphiUniversal Immunization ProgrammeAntimicrobial ResistanceXDR typhoidfluoroquinolonesExtensive Drug-Resistantvaccine integration policy

Public Health Experts Advocate Typhoid Vaccine Integration into Immunization Schedule

More in Science & Technology